Feb 09,2022

DarioHealth Publishes Clinical Outcomes Demonstrating the Impact of Using a Single Digital Therapeutics Platform for Multiple Conditions

New peer-reviewed study sheds light on the effectiveness of an integrated approach for Dario users with both diabetes and high blood pressure.

CLINICAL STUDY

#dtx

View Analyst & Ambassador Comments
Go to original news
Mar 09,2022

DarioHealth Announces Two New Contracts within the Employer and Provider Market

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today new agreements with a regional employer and a regional provider. The contracts are expected to launch in the second quarter of 2022.

View Analyst & Ambassador Comments
Go to original news
Mar 29,2022

Innit Unveils Joint Solutions With Google Cloud for Health and Wellness

Innit, an innovator in personalized food technology, announced an expansion of its strategic partnership with Google Cloud, launching joint health and wellness solutions to support healthy eating for a range of conditions such as diabetes, hypertension, obesity, and heart disease.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Apr 05,2022

Lark Health Announces Lark for Salesforce on Salesforce AppExchange, the World’s Leading Enterprise Cloud Marketplace

Lark Health announced it has launched Lark for Salesforce on Salesforce AppExchange, empowering customers to simplify care management for health plans and their members with enhanced technology, providing a simple and digestible way for members to engage in their care.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Apr 14,2022

DarioHealth Announces Agreement with Health Plan Colorado Access

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today a new agreement with Colorado Access, the largest public sector health plan in the state of Colorado, to provide digital chronic condition management solutions for its Medicaid population beginning with thousands of its members in the second quarter of 2022.

COLLABORATION PARTNERSHIP

#insurance

View Analyst & Ambassador Comments
Go to original news
Apr 29,2022

CareSignal Partners with Texas Association of Community Health Centers (TACHC) to Improve Outcomes for Underserved Patient Populations

Participating centers now offer CareSignal’s Deviceless Remote Patient Monitoring® technology to patients to monitor diabetes, hypertension, congestive heart failure, COPD, and social determinants of health.

COLLABORATION PARTNERSHIP

#product & service

#rpm

View Analyst & Ambassador Comments
Go to original news
May 05,2022

Welldoc’s BlueStar Named 2022 “Best Overall Connected Healthcare Solution” in 2022 MedTech Breakthrough Awards Program

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, today announced that Welldoc®, a digital health leader revolutionizing chronic care, has been selected as winner of the “Best Overall Connected Healthcare Solution” award in the sixth annual MedTech Breakthrough Awards program.

PRODUCT

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
May 10,2022

Vida Health Announces Medical Prescribing Services for Physical and Mental Health

Vida Health announced its expansion into new medical prescribing services for treating physical and mental health conditions together, solidifying its position as a leader in comprehensive cardiometabolic virtual care.

PRODUCT

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jun 03,2022

DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association's 82nd Scientific Sessions

Two of the new studies add to Dario's growing body of evidence in support of an integrated approach to managing multiple chronic conditions by examining the impact of Dario's solution on users with co-occurring physical and mental conditions. The third study analyzed the impact across the ethnicities of users living with Type 2 diabetes.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Jun 16,2022

Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform

Welldoc®, a digital health leader revolutionizing chronic care, today announced that the company’s 31st patent was granted on June 14, 2022, demonstrating the continued advancement of Welldoc’s first-in-class technology for comprehensive chronic condition management.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Subscribe to HYPERTENSION